Literature DB >> 24212365

Variability of platelet-rich plasma preparations.

Ryan P Russell1, John Apostolakos, Toshiaki Hirose, Mark P Cote, Augustus D Mazzocca.   

Abstract

Platelet-rich plasma (PRP) as a clinical treatment for bone, muscle, tendon, and cartilage injury has gained popularity in the field of orthopedic sports medicine. The use of a patient's own blood is an appealing aspect of PRP treatment, as the resulting plasma preparation is considered relatively benign in comparison with more common, potentially caustic treatments such as corticosteroids and anesthetics. Although appealing, the autologous nature of PRP introduces variability to plasma preparations, creating challenges for both the researcher and the clinician. Differences in patients at the time of blood draw result in plasma preparations that vary within as well as between patients. This variability is compounded by the multitude of protocols and devices available for procuring PRP. The variability of components and its effects on dosage should be considered in single or consecutive treatments of PRP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24212365     DOI: 10.1097/JSA.0000000000000007

Source DB:  PubMed          Journal:  Sports Med Arthrosc Rev        ISSN: 1062-8592            Impact factor:   1.985


  24 in total

Review 1.  Platelet-Rich Plasma for the Treatment of Tissue Infection: Preparation and Clinical Evaluation.

Authors:  Wenhai Zhang; Yue Guo; Mitchell Kuss; Wen Shi; Amy L Aldrich; Jason Untrauer; Tammy Kielian; Bin Duan
Journal:  Tissue Eng Part B Rev       Date:  2019-05-15       Impact factor: 6.389

Review 2.  Learning about PRP using cell-based models.

Authors:  Knut Beitzel; Mary Beth McCarthy; Ryan P Russell; John Apostolakos; Mark P Cote; Augustus D Mazzocca
Journal:  Muscles Ligaments Tendons J       Date:  2014-05-08

3.  Advancing biomaterials of human origin for tissue engineering.

Authors:  Fa-Ming Chen; Xiaohua Liu
Journal:  Prog Polym Sci       Date:  2015-03-28       Impact factor: 29.190

4.  A novel platelet lysate hydrogel for endothelial cell and mesenchymal stem cell-directed neovascularization.

Authors:  Scott T Robinson; Alison M Douglas; Tatiana Chadid; Katie Kuo; Ajai Rajabalan; Haiyan Li; Ian B Copland; Thomas H Barker; Jacques Galipeau; Luke P Brewster
Journal:  Acta Biomater       Date:  2016-03-04       Impact factor: 8.947

5.  Use of Platelet-Rich Plasma for the Improvement of Pain and Function in Rotator Cuff Tears: A Systematic Review and Meta-analysis With Bias Assessment.

Authors:  Xiao Chen; Ian A Jones; Ryan Togashi; Caron Park; C Thomas Vangsness
Journal:  Am J Sports Med       Date:  2019-11-19       Impact factor: 6.202

6.  Comparison of Two Anticoagulants for Pain Associated with Platelet-Rich Plasma Injections.

Authors:  Metin Görgü; Ali Gökkaya; Ali Doğan
Journal:  Aesthetic Plast Surg       Date:  2019-11-13       Impact factor: 2.326

7.  Site-specific targeting of platelet-rich plasma via superparamagnetic nanoparticles.

Authors:  Tara Talaie; Stephen J P Pratt; Camilo Vanegas; Su Xu; R Frank Henn; Paul Yarowsky; Richard M Lovering
Journal:  Orthop J Sports Med       Date:  2015-01-22

8.  Platelet-rich plasma therapy: A novel application in regenerative medicine.

Authors:  Ashish Jain; Ravneet Kaur Bedi; Kshitija Mittal
Journal:  Asian J Transfus Sci       Date:  2015 Jul-Dec

9.  Advantages of Pure Platelet-Rich Plasma Compared with Leukocyte- and Platelet-Rich Plasma in Treating Rabbit Knee Osteoarthritis.

Authors:  Wen-Jing Yin; Hai-Tao Xu; Jia-Gen Sheng; Zhi-Quan An; Shang-Chun Guo; Xue-Tao Xie; Chang-Qing Zhang
Journal:  Med Sci Monit       Date:  2016-04-17

10.  Regenerative therapies for equine degenerative joint disease: a preliminary study.

Authors:  Sarah Broeckx; Marieke Zimmerman; Sara Crocetti; Marc Suls; Tom Mariën; Stephen J Ferguson; Koen Chiers; Luc Duchateau; Alfredo Franco-Obregón; Karin Wuertz; Jan H Spaas
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.